Journals / Türk Kardiyoloji Derneği Arşivi / 2005 / Cilt: 33 - Sayı: 8

The relationship between serum myeloperoxidase levels and major cardiovascular events in patients with acute coronary syndrome

Akut koroner sendromlu hastalarda serum miyeloperoksidaz düzeyi ile erken dönemdeki majör kardiyak olaylar arasındaki ilişki

Pages
452–459
Publication Date
2022-11-05
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

No significant differences were observed between patients with high and low MPO levels with respect to the development of arrhythmia, reinfarction, recurrent angina, and clinical heart failure (p>0.05).Conclusion: The results of this study demonstrate that elevated MPO levels predict death during hospital stay and 30-day follow-up period in patients with acute coronary syndrome.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Objectives: This study was planned to assess the relationship between serum myeloperoxidase (MPO) levels and major cardiovascular events in patients with acute coronary syndrome.Study design: Serum MPO levels were measured by ELISA on admission of 243 consecutive patients with acute coronary syndrome (153 acute myocardial infarction, 90 unstable angina).
📊
Key Findings & Data:Major cardiac events that occurred during hospitalization and 30-day follow-up period included recurrent angina, reinfarction, ventricular (ventricular tachycardia, ventricular fibrillation) and supraventricular (atrial fibrillation, supraventricular tachycardia) arrhythmias, complete atrioventricular block, clinical heart failure, and death.
💡
Conclusion & Impact:No significant differences were observed between patients with high and low MPO levels with respect to the development of arrhythmia, reinfarction, recurrent angina, and clinical heart failure (p>0.05).Conclusion: The results of this study demonstrate that elevated MPO levels predict death during hospital stay and 30-day follow-up period in patients with acute coronary syndrome.
🔬Design:Modeling & Simulation
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Objectives: This study was planned to assess the relationship between serum myeloperoxidase (MPO) levels and major cardiovascular events in patients with acute coronary syndrome.Study design: Serum MPO levels were measured by ELISA on admission of 243 consecutive patients with acute coronary syndrome (153 acute myocardial infarction, 90 unstable angina). Major cardiac events that occurred during hospitalization and 30-day follow-up period included recurrent angina, reinfarction, ventricular (ventricular tachycardia, ventricular fibrillation) and supraventricular (atrial fibrillation, supraventricular tachycardia) arrhythmias, complete atrioventricular block, clinical heart failure, and death. Correlations were sought between high (n=70, >350 µg/l) and low (n=173, ≤350 µg/l) MPO levels and major events. Relative risks were estimated using the Cox proportional hazards regression model.Results: The incidence of hypercholesterolemia was significantly higher in patients with high levels of MPO (p=0.008). A significant association was found between high levels of MPO and increased mortality risk during both hospitalization (hazard ratio-HR, 3.91; 95% CI 1.12-13.6; p=0.03) and 30-day follow-up period (HR 5.08, 95% CI 1.64-15.7; p=0.005). No significant differences were observed between patients with high and low MPO levels with respect to the development of arrhythmia, reinfarction, recurrent angina, and clinical heart failure (p>0.05).Conclusion: The results of this study demonstrate that elevated MPO levels predict death during hospital stay and 30-day follow-up period in patients with acute coronary syndrome.

Özet

Amaç: Bu çalışmada akut koroner sendromlu hastalarda serum miyeloperoksidaz (MPO) düzeyleri ile erken dönem majör kardiyovasküler olaylar arasındaki ilişki araştırıldı.Çalışma planı: Akut koroner sendromlu ardışık 243 hastada (153 akut miyokard infarktüsü, 90 kararsız angina pektoris) başvuru sırasında ELISA tekniğiyle serum MPO düzeyleri ölçüldü. Hastanede yatış sırasında ve yatıştan itibaren 30 gün içinde görülen tekrarlayan angina, infarktüs, ventrikül aritmileri (ventrikül taşikardisi, ventrikül fibrilasyonu), supraventriküler aritmiler (atriyum fibrilasyonu, supraventrikül taşikardisi), ileri atriyoventriküler blok, klinik kalp yetersizliği ve ölüm majör kardiyak olaylar olarak tanımlandı ve bunların MPO düzeyleriyle (n=173, ≤350 µg/l; n=70, >350 µg/l) ilişkisi değerlendirildi. Majör kardiyak olay riskinin tahmininde Cox proportional hazard regresyon modeli kullanıldı.Bulgular: Yüksek MPO düzeyi saptanan hastalarda hiperkolesterolemi oranı anlamlı derecede yüksek bulundu (p=0.008). Ayrıca, bu grupta hastanede yatış süresi boyunca (risk oranı 3.91, %95 güven aralığı 1.12-13.6; p=0.03) ve 30 günlük takipte (risk oranı 5.08, %95 güven aralığı 1.64-15.7; p=0.005) ölüm riskinin anlamlı derecede yüksek olduğu görüldü. Aritmi ve tekrarlayan infarktüs, tekrarlayan angina ve klinik kalp yetersizliği açısından yüksek ve düşük MPO düzeyi olan hastalar arasında anlamlı fark saptanmadı (p>0.05).Sonuç: Bulgularımız yüksek MPO düzeylerinin akut koroner sendromlu hastalarda hastanede yatış süresi ve 30 günlük takip boyunca gelişecek ölümün bağımsız belirleyicisi olduğunu göstermektedir.

🔖

Cite This Article

GÜRLERTOP, H. Y., EROL, M. K., ARSLAN, Ş., BOZKURT, E., KIZILTUNÇ, A. (2022). The relationship between serum myeloperoxidase levels and major cardiovascular events in patients with acute coronary syndrome. Türk Kardiyoloji Derneği Arşivi, Cilt: 33 - Sayı: 8, 452–459. https://ajindex.com/articles/633755

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (13)

  1. Davies MJ. A macro and micro view of coronary vascular insult in ischemic heart disease. Circulation 1990; 82(3 Suppl):II38-46
  2. Fuster V, Badimon L, Badimon JJ, Chesebro JH. The pathogenesis of coronary artery disease and the acute coronary syndromes (1). N Engl J Med 1992;326:242 50
  3. Fuster V. Lewis A. Conner Memorial Lecture. Mechanisms leading to myocardial infarction: insights from studies of vascular biology. Circulation 1994;90: 2126-46. 4. de Servi S, Mazzone A, Ricevuti G, Mazzucchelli I, Fossati G, Angoli L, et al. Expression of neutrophil and monocyte CD11B/CD18 adhesion molecules at different sites of the coronary tree in unstable angina pectoris. Am J Cardiol 1996;78:564-8
  4. Dinerman JL, Mehta JL, Saldeen TG, Emerson S, Wallin R, Davda R, et al. Increased neutrophil elastase release in unstable angina pectoris and acute myocardial infarction. J Am Coll Cardiol 1990;15:1559-63
  5. Buffon A, Biasucci LM, Liuzzo G, D’Onofrio G, Crea F, Maseri A. Widespread coronary inflammation in unstable angina. N Engl J Med 2002;347:5-12
  6. Davies MJ, Thomas A. Thrombosis and acute coronary-artery lesions in sudden cardiac ischemic death. N Engl J Med 1984;310:1137-40
  7. Naruko T, Ueda M, Haze K, van der Wal AC, van der Loos CM, Itoh A, et al. Neutrophil infiltration of culprit lesions in acute coronary syndromes. Circulation 2002; 106:2894-900
  8. Zhang R, Brennan ML, Fu X, Aviles RJ, Pearce GL, Penn MS, et al. Association between myeloperoxidase levels and risk of coronary artery disease. JAMA 2001; 286:2136-42
  9. Sugiyama S, Okada Y, Sukhova GK, Virmani R, Heinecke JW, Libby P. Macrophage myeloperoxidase regulation by granulocyte macrophage colony stimulating factor in human atherosclerosis and implications in acute coronary syndromes. Am J Pathol 2001;158: 879-91
  10. Sabatine MS, Morrow DA, de Lemos JA, Gibson CM, Murphy SA, Rifai N, et al. Multimarker approach to risk stratification in non-ST elevation acute coronary syndromes: simultaneous assessment of troponin I, C-reactive protein, and B type natriuretic peptide. Circulation 2002;105:1760-3
  11. Ferreiros ER, Boissonnet CP, Pizarro R, Merletti PF, Corrado G, Cagide A, et al. Independent prognostic value of elevated C-reactive protein in unstable angina. Circulation 1999;100:1958-63
  12. Baldus S, Heeschen C, Meinertz T, Zeiher AM, Eiserich JP, Munzel T, et al. Myeloperoxidase serum levels predict risk in patients with acute coronary syndromes. Circulation 2003;108:1440-5
  13. Brennan ML